{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:11:46Z","timestamp":1790079106352,"version":"4.0.1"},"reference-count":23,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Gender-affirming testosterone therapy is an essential component of medical transition for transgender men. Despite its widespread use, the histopathological effects of testosterone exposure on the uterus, ovaries, and fallopian tubes remain incompletely characterized. This study aimed to characterize histopathological findings in the gynecologic organs of transgender men receiving testosterone therapy before gender-affirming hysterectomy with bilateral salpingo-oophorectomy. Methods: This retrospective cohort study included transgender men who underwent laparoscopic hysterectomy with bilateral salpingo-oophorectomy at a tertiary referral center between 2015 and 2019. Demographic characteristics, duration of testosterone therapy, operative findings, and histopathological results were reviewed. Estrogen receptor (ER) and progesterone receptor (PR) expression in uterine tissues was assessed immunohistochemically. Results: Fifty-two transgender men were included. The median age was 25.5 years (range, 19\u201346 years), the median body mass index was 24.8 kg\/m2, and the mean duration of testosterone therapy was 16.1 \u00b1 7.8 months. Proliferative endometrium was the predominant pattern (78.8%), followed by inactive (17.3%) and atrophic (3.8%) endometrium. Endometrial polyps were identified in 13.5% of patients. Multifollicular ovarian morphology was observed in 90.4%, and paratubal cysts in 63.5%. No premalignant or malignant lesions were detected. ER expression was positive in all endometrial samples and in 92% of myometrial specimens, while PR expression was preserved in all evaluated uterine tissues. Conclusions: In this cohort, proliferative endometrium and multifollicular ovarian morphology were common despite testosterone therapy, and uterine ER and PR expression remained detectable. The absence of premalignant or malignant lesions was reassuring within the observed exposure period; however, the retrospective design, modest sample size, absence of a control group, limited characterization of hormone exposure, and lack of longitudinal follow-up preclude conclusions regarding long-term oncologic safety or malignancy risk.<\/jats:p>","DOI":"10.3390\/jcm15187304","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:09:35Z","timestamp":1790075375000},"page":"7304","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histopathological Changes in the Uterus, Ovaries, and Fallopian Tubes Following Testosterone Therapy in Transgender Men: A Retrospective Cohort Study from a Tertiary Referral Center"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-8301","authenticated-orcid":false,"given":"K\u00fcbra Hamzao\u011flu","family":"Canbolat","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3004-0102","authenticated-orcid":false,"given":"Hilal","family":"At\u0131lgan Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kartal L\u00fctfi K\u0131rdar City Hospital, Istanbul 34865, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9588-4870","authenticated-orcid":false,"given":"Nil","family":"Urganc\u0131","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eennur","family":"\u0130lvan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9634-3651","authenticated-orcid":false,"given":"Mahmut","family":"\u00d6nc\u00fcl","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koray","family":"G\u00f6k","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"T\u00fcten","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Cerrahpa\u015fa Faculty of Medicine, Istanbul University-Cerrahpa\u015fa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of Care for the Health of Transgender and Gender Diverse People, Version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int. J. Transgend. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine Treatment of Gender-Dysphoric\/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1093\/humrep\/dem310","article-title":"Estrogen Metabolizing Enzymes in Endometrium and Endometriosis","volume":"22","author":"Dassen","year":"2007","journal-title":"Hum. Reprod."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens Stimulate Early Stages of Follicular Growth in the Primate Ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tjog.2016.03.004","article-title":"Uterine and Ovarian Changes during Testosterone Administration in Young Female-to-Male Transsexuals","volume":"55","author":"Loverro","year":"2016","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/trgh.2022.0207","article-title":"Uterine and Ovarian Histopathology after Testosterone for Gender Affirmation: A Systematic Review","volume":"9","author":"Toland","year":"2024","journal-title":"Transgend. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2018.12.021","article-title":"Uterine Pathology in Transmasculine Persons on Testosterone: A Retrospective Multicenter Case Series","volume":"220","author":"Grimstad","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.fertnstert.2020.11.008","article-title":"Endometrial Findings among Transgender and Gender Nonbinary People Using Testosterone at the Time of Gender-Affirming Hysterectomy","volume":"115","author":"Hawkins","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jcem-69-1-151","article-title":"The Effects of Long Term Testosterone Administration on Pulsatile Luteinizing Hormone Secretion and on Ovarian Histology in Eugonadal Female to Male Transsexual Subjects","volume":"69","author":"Spinder","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-62-1-16","article-title":"Histopathological Effects of Exogenously Administered Testosterone in 19 Female to Male Transsexuals","volume":"62","author":"Futterweit","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e142029","DOI":"10.1172\/JCI142029","article-title":"Research gaps in medical treatment of transgender\/nonbinary people","volume":"131","author":"Safer","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Toland, M., Bentz, J., Bonasia, K., Damiano, E.A., DelBaugh, R.M., and Gerjevic, K.A. (2023). Uterine and Ovarian Histopathology in Transmasculine and Nonbinary Patients on Testosterone Compared to Cisgender Control Patients [ID: 1381367]. Obstet. Gynecol., 141.","DOI":"10.1097\/01.AOG.0000929752.88321.bf"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pereda, M.M., Vergara, M.A., Morente, L.S., Gonz\u00e1lez-Mesa, E., Reina, P.E., and L\u00f3pez, J.S.J. (2021). Hysterectomy and Bilateral Salpingoophorectomy in Female-to-Male Transsexual: Does Testosterone Induce Anatomopatological Changes? A Retrospective Study. Res. Sq., preprint.","DOI":"10.21203\/rs.3.rs-539814\/v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"bvae163.1632","DOI":"10.1210\/jendso\/bvae163.1632","article-title":"Masculinizing Hormone Therapy and Gynecological Neoplasm: A Single Institution Cohort","volume":"8","author":"Korpaisarn","year":"2024","journal-title":"J. Endocr. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103248","DOI":"10.1016\/j.eclinm.2025.103248","article-title":"Incidence of Gynaecological (Pre-)Malignancies and Endometrial Activity in Transmasculine and Gender Diverse Individuals Using Testosterone: A Retrospective, Single-Centre Cohort Study","volume":"84","author":"Vestering","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ejendo\/lvae096","article-title":"Uterine Changes in Transgender Men Receiving Testosterone Therapy","volume":"191","author":"Riveri","year":"2024","journal-title":"Eur. J. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101440","DOI":"10.1016\/j.xcrm.2024.101440","article-title":"One-Third of Amenorrheic Transmasculine People on Testosterone Ovulate","volume":"5","author":"Asseler","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1093\/ajcp\/aqad150.118","article-title":"A Rare Case of Poorly-Differentiated Endometrial Carcinoma in a Female-to-Male Transgender Man on Testosterone Therapy","volume":"160","author":"Riahi","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"A789","DOI":"10.1210\/jendso\/bvab048.1605","article-title":"Case Report: Invasive Endometrial Cancer in a Trans Man and Risk of Testosterone Therapy","volume":"5","author":"Jeevananthan","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"534.e1","DOI":"10.1016\/j.ajog.2024.06.004","article-title":"Management of Breakthrough Bleeding in Transgender and Gender Diverse Individuals on Testosterone","volume":"231","author":"Grimstad","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Middleton, R., Scatoni, A., Boskey, E.R., and Grimstad, F. (2025). Assessing the Role of Ultrasound in Uterine Bleeding among Patients on Gender-Affirming Testosterone: A Retrospective Cohort Study. BMC Med. Imaging, 25.","DOI":"10.1186\/s12880-025-01957-x"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e220102","DOI":"10.1530\/RAF-22-0102","article-title":"The Ovaries of Transgender Men Indicate Effects of High-Dose Testosterone on the Primordial and Early Growing Follicle Pool","volume":"4","author":"Bailie","year":"2023","journal-title":"Reprod. Fertil."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/0046-8177(94)90037-X","article-title":"Androgen Receptor Expression in Human Ovarian and Uterine Tissue of Long Term Androgen-Treated Transsexual Women","volume":"25","author":"Chadha","year":"1994","journal-title":"Hum. Pathol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:33:00Z","timestamp":1790076780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":23,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187304"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187304","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]}}}